# Lantheus Holdings, Inc. – Consensus ‘buy’ rating and 72.8% Upside Potential

- Link: https://www.directorstalkinterviews.com/lantheus-holdings-inc.consensus-buy-rating-and-72.8-upside-potential/4121130919
- Published: 2023-10-26T14:12:04+01:00
- Author: Charlotte Edwards

**Lantheus Holdings, Inc.** which can be found using ticker (LNTH) have now 8 analysts
in total covering the stock. The consensus rating is pointing to ‘buy’. The target
price High/Low ranges between 130 and 100 suggesting an average Analsyt target price
of $118.38. Given that the stocks previous close was at $68.51 this would indicate
that there is a potential upside of 72.8%. It’s also worth noting that there is 
a 50 day moving average of $67.05 and the 200 day MA is $75.87. The company has 
a market capitalization of 4.54B. The current share price for the company is: 66.38
USD

 The potential market cap would be $7,848,968,434 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 135.47, revenue per share of 16.46
and a 8.4% return on assets.

Lantheus Holdings, Inc. is an integrated provider of imaging diagnostics, targeted
therapeutics, and artificial intelligence solutions to find, fight and follow serious
medical conditions. The Company’s products include precision diagnostics, radiopharmaceutical
oncology, and strategic partnerships. Its precision diagnostic products assist healthcare
professionals (HCPs) Find and Follow diseases, with a focus on cardiology. Its radiopharmaceutical
oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Its
strategic partnerships focus on enabling precision medicine through the use of biomarkers,
digital solutions and pharma services platforms, and also includes the Company’s
license of RELISTOR to Bausch Health Companies, Inc. (Bausch). Its commercial products
are used by oncologists, urologists, nuclear medicine physicians, cardiologists,
sonographers, technologists, radiologists, and internal medicine physicians working
in a variety of clinical settings.

Share on: